BMC Medical Genetics BioMed Central G4Research article Open Access Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients Ivan J Delgado1,4, Dong Sun Kim1,5, Karen N Thatcher2, Janine M LaSalle2 and Ignatia B Van den Veyver*1,3 Address: 1Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, USA, 2Medical Microbiology and Immunology and Rowe Program in Human Genetics, School of Medicine, University of California, Davis, CA, USA, 3Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA, 4Senior Scientist, Identigene Inc., 5615 Kirby, Suite 800 Houston, TX 77005, USA and 5Assistant Professor, Department of Anatomy, School of Medicine, Kyungpook National University, South Korea Email: Ivan J Delgado -
[email protected]; Dong Sun Kim -
[email protected]; Karen N Thatcher -
[email protected]; Janine M LaSalle -
[email protected]; Ignatia B Van den Veyver* -
[email protected] * Corresponding author Published: 21 July 2006 Received: 25 October 2005 Accepted: 21 July 2006 BMC Medical Genetics 2006, 7:61 doi:10.1186/1471-2350-7-61 This article is available from: http://www.biomedcentral.com/1471-2350/7/61 © 2006 Delgado et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: More than 85% of Rett syndrome (RTT) patients have heterozygous mutations in the X-linked MECP2 gene which encodes methyl-CpG-binding protein 2, a transcriptional repressor that binds methylated CpG sites.